Be cautiously optimistic, and focused on the medium term: 5 mid-cap stocks with upside potential of up to 28%As the mood of the market changes, the stance should be the same as what we have been advocating these past few weeks: Cautious optimism. T...
17 Nov, 2026, 04.23 PM IST
Laurus Labs shares tumble nearly 9% after promoters sell stake worth Rs 500 crore; multibagger stock up 122% in one yearLaurus Labs shares fell nearly 9% after promoters, including founder and CEO Satyanarayana Chava, sold over 20 lakh shares worth Rs 487 cro...
16 Nov, 2026, 02.26 PM IST
Glenmark launches generic of Inlyta tablets for kidney cancer treatment in USGlenmark Pharmaceuticals Inc has announced the launch of Axitinib Tablets in the United States in two strengths. These tablets are a generi...
16 Nov, 2026, 12.36 PM IST
Lupin partner Sandoz launches RanluspecTM across Europe for retinal disease treatmentLupin Ltd has partnered with Sandoz to launch RanluspecTM, a biosimilar for Ranibizumab, across Europe. This launch will help to improve ac...
12 Nov, 2026, 12.21 PM IST
Pharma & healthcare funds top mutual fund return charts with over 19% gains. Should investors invest now or wait for a correction?Pharma and healthcare mutual funds have topped return charts in 2026 with over 19% gains. While strong sector growth supports the outlook, ...
11 Nov, 2026, 11.00 AM IST
BDR Pharma to acquire Acme’s oral solid formulations businessBDR Pharma will acquire a controlling stake in Acme Formulation’s oral solid formulations business from existing shareholders, led by priva...
10 Nov, 2026, 04.21 PM IST
Q2 Earnings Scorecard: Which sectors outperformed and which fell behind?The September quarter results indicate strong revenue and profit growth in sectors like automobiles and banking. In contrast, sectors such ...
10 Nov, 2026, 06.51 AM IST
Over 1,300 anti-cancer drugs to get cheaperIndia's National Pharmaceutical Pricing Authority is set to cap trade margins on anti-cancer drugs starting November 2026. The initiative a...
10 Nov, 2026, 01.00 AM IST
Sebi approves 6 IPOs including Mahanadi Coalfields, Veritas Finance and Sagar Defence. Check detailsSebi has granted approval for initial public offerings from six companies across various sectors. Companies like Mahanadi Coalfields and Sa...
09 Nov, 2026, 07.41 PM IST
Morepen Laboratories launches Desloratadine (Rx) generic drug product in US marketMorepen Laboratories has launched its prescription generic product Desloratadine in the United States market. This launch is managed throug...
09 Nov, 2026, 11.03 AM IST
Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its t...
09 Nov, 2026, 10.39 AM IST
For long- and medium-term investors: Cycles turn, principles don’t; 5 large-cap stocks with upside potential of up to 29%These are the stocks that fell the most, so they may bounce back the most if the fund flows return. They are the ones FPI money will target...
08 Nov, 2026, 07.02 AM IST
Pharma industry steps up API investments to cut import dependence, move up value chainIndia's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Invest...
07 Nov, 2026, 05.39 PM IST
Pills are paying off! Pharma stocks lead 2026 rally with up to 112% returnIn 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic dem...
05 Nov, 2026, 11.49 AM IST
Alkem Laboratories appoints Amrut Naik as CEOAlkem Laboratories announced the appointment of Amrut Naik as its new Chief Executive Officer. His appointment is effective from November 1...
03 Nov, 2026, 04.55 PM IST
Sun Pharma’s specialty portfolio, Organon deal to drive growthSun Pharmaceutical achieved notable revenue growth in the September quarter, driven by strong performance in India and specialty medicines....
02 Nov, 2026, 06.48 AM IST
Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
31 Oct, 2026, 11.47 PM IST